Immatics Biotechnologies GmbH:企業の戦略的SWOT分析

◆英語タイトル:Immatics Biotechnologies GmbH - Strategic SWOT Analysis Review
◆商品コード:SWOT20MY2859
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Immatics Biotechnologies GmbH – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Immatics Biotechnologies GmbH (Immatics) is a clinical stage biopharmaceutical company that develops drugs for the treatment of cancer. It develops peptide based active immunotherapy drug candidates based on it novel technology, XPRESIDENT discovery platform. The company has active programs in several tumor types including gastric cancer, non-small-cell lung cancer and prostate cancer. Its major drug candidates include IMA101, IMA201, IMA202, IMA203, and IMA301 which are focused on the development of three ACT approaches ACTolog, ACTengine, and ACTallo to treat cancer. The company has collaborations with Roche, UTHealth and MorphoSys for the advancement of drug candidates. Immatics is headquartered in Tuebingen, Germany.

Immatics Biotechnologies GmbH Key Recent Developments

Feb 21,2020: GSK and Immatics partner on cell therapies for cancer
Nov 12,2019: Immatics Implements Genedata Biologics into proprietary T-cell receptor discovery and engineering XCEPTOR platform
Jul 08,2019: Immatics appoints Harpreet Singh as chief executive officer
May 13,2019: Immatics to present at CIMT Annual Meeting 2019 (May 21-23) in Mainz, Germany
Feb 27,2019: Immatics and Roche to trial combination therapy for solid tumours

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Immatics Biotechnologies GmbH – Key Facts
Immatics Biotechnologies GmbH – Key Employees
Immatics Biotechnologies GmbH – Key Employee Biographies
Immatics Biotechnologies GmbH – Major Products and Services
Immatics Biotechnologies GmbH – History
Immatics Biotechnologies GmbH – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Immatics Biotechnologies GmbH – Business Description
Immatics Biotechnologies GmbH – SWOT Analysis
SWOT Analysis – Overview
Immatics Biotechnologies GmbH – Strengths
Immatics Biotechnologies GmbH – Weaknesses
Immatics Biotechnologies GmbH – Opportunities
Immatics Biotechnologies GmbH – Threats
Immatics Biotechnologies GmbH – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Immatics Biotechnologies GmbH, Recent Deals Summary
Section 4 – Company’s Recent Developments
Feb 21, 2020: GSK and Immatics partner on cell therapies for cancer
Nov 12, 2019: Immatics Implements Genedata Biologics into proprietary T-cell receptor discovery and engineering XCEPTOR platform
Jul 08, 2019: Immatics appoints Harpreet Singh as chief executive officer
May 13, 2019: Immatics to present at CIMT Annual Meeting 2019 (May 21-23) in Mainz, Germany
Feb 27, 2019: Immatics and Roche to trial combination therapy for solid tumours
Jan 11, 2019: Immatics at the 18th PepTalk in San Diego, CA
Jan 03, 2019: US Patent Office Grants the 100th Patent to Immatics Underpinning the Company’s Leading Role in the Field of Innovative Immunotherapies
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Immatics Biotechnologies GmbH, Key Facts
Immatics Biotechnologies GmbH, Key Employees
Immatics Biotechnologies GmbH, Key Employee Biographies
Immatics Biotechnologies GmbH, Major Products and Services
Immatics Biotechnologies GmbH, History
Immatics Biotechnologies GmbH, Other Locations
Immatics Biotechnologies GmbH, Subsidiaries
Immatics Biotechnologies GmbH, Key Competitors
Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Immatics Biotechnologies GmbH, Recent Deals Summary

List of Figures
Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Immatics Biotechnologies GmbH:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Corpak MedSystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Corpak MedSystems Inc (Corpak), a subsidiary of Halyard Health Inc is a medical device company that manufactures and markets enteral feeding safety devices. The company offers products such as cortrak systems, gastrostomy, nasoenteric systems, gastric decompression, NICU products and accesso …
  • Sinohydro Corporation Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Sinohydro Corporation Co., Ltd (Sinohydro), a subsidiary of China Hydropower Construction Group International Engineering Co., Ltd., is an engineering and construction company. Its portfolio of services includes general construction, engineering, procurement and construction (EPC), and inves …
  • Clinigen Group Plc (CLIN):製薬・医療:M&Aディール及び事業提携情報
    Summary Clinigen Group Plc (Clinigen Group) is a pharmaceutical and services company that provides access to clinical trials, medicines, unlicensed and commercial supply. The company acquires and licenses essential commercial medicines such as foscavir, cardioxane, ethyol, savene and vibativ. It off …
  • Department of Defense Education Activity:企業の戦略的SWOT分析
    Department of Defense Education Activity - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Milo Biotechnology LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Milo Biotechnology LLC (Milo) is a biotechnology company that develops novel therapies based on follistatin, a protein that increases muscle mass and strength. The company’s pipeline product includes AAV1 (based on adeno-associated virus), which is a gene therapy for the one time treatment o …
  • Genesis Healthcare, Inc.:企業の戦略・SWOT・財務情報
    Genesis Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report Summary Genesis Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Prologis, Inc.:企業の戦略・SWOT・財務情報
    Prologis, Inc. - Strategy, SWOT and Corporate Finance Report Summary Prologis, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Cloverdale Paint Inc:企業の戦略的SWOT分析
    Cloverdale Paint Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • The Bank of Okinawa, Ltd. (8397):企業の財務・戦略的SWOT分析
    The Bank of Okinawa, Ltd. (8397) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Yellowstone Valley Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Yellowstone Valley Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • High Plains Power Inc:企業の戦略的SWOT分析
    High Plains Power Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • HTG Molecular Diagnostics Inc (HTGM):製薬・医療:M&Aディール及び事業提携情報
    Summary HTG Molecular Diagnostics Inc (HTG) is a technology company that provides molecular technology solutions. The company provides products such as HTG edge system, HTG edgeseq reagents and HTG edgeseq immuno-oncology biomarker panel assay, among others. It develops assays and reagent systems th …
  • Kone Corporation
    Kone Corporation - Strategy, SWOT and Corporate Finance Report Summary Kone Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Vivimed Labs Ltd (VIVIMEDLAB):企業の財務・戦略的SWOT分析
    Vivimed Labs Ltd (VIVIMEDLAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Rio Tinto:企業のM&A・事業提携・投資動向
    Rio Tinto - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rio Tinto Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Pharmathen Global BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmathen Global BV (Pharmathen) is a pharmaceutical company with focus on the research and development of generics, active pharmaceutical ingredients (APIs), and finished formulations. Its vast product portfolio includes antibiotics, antimycotics, antivirals, antidiabetics and topical pain …
  • Wien Energie GmbH:企業の戦略的SWOT分析
    Wien Energie GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • RIKEN:製薬・医療:M&Aディール及び事業提携情報
    Summary RIKEN is a research organization that carries out basic and applied science research programs. The organization’s research system consists of strategic research centers, research infrastructure centers, chief scientist system, etc. and a cluster for industry partnerships. Its centers, resear …
  • Petromin Resources Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Petromin Resources Ltd (Petromin) is an oil and gas exploration and production company that acquires, explores, develops and produces petroleum and natural gas. The company’s projects include Gilby, Redwater, Frog Lake and MorningSide projects in Alberta, Canada. It also explores and develop …
  • Television Francaise 1 SA:企業の戦略・SWOT・財務情報
    Television Francaise 1 SA - Strategy, SWOT and Corporate Finance Report Summary Television Francaise 1 SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆